{
  "symbol": "PRQR",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Biotechnology sector is prone to speculation",
      "Small market capitalization",
      "RNA-based therapeutics are a cutting-edge technology"
    ],
    "riskScore": 7,
    "reason": "ProQR operates in the speculative biotech sector with a small market cap and cutting-edge RNA technology, making it susceptible to retail-driven volatility."
  }
}